MAKO Surgical Corp (MAKO) Misses Q4 EPS by 2c

Go back to MAKO Surgical Corp (MAKO) Misses Q4 EPS by 2c

Oppenheimer Trims PT on MAKO (MAKO) to $13

February 27, 2013 8:55 AM EST

Oppenheimer maintained its Perform rating and trimmed its price target on MAKO Surgical (NASDAQ: MAKO) from $14 to $13 following no major surprises in Q4 report.

"Management noted it is hearing some "noise" on new competitive alternatives, but maintains it is not... More